141 related articles for article (PubMed ID: 11646728)
1. F.D.A. gives quick approval to two drugs to treat AIDS.
Kolata G
N Y Times Web; 1989 Jun; ():A1, B4. PubMed ID: 11646728
[No Abstract] [Full Text] [Related]
2. F.D.A., in big shift, will permit use of experimental AIDS drug.
Hilts PJ
N Y Times Web; 1989 Sep; ():A1, A16. PubMed ID: 11646735
[No Abstract] [Full Text] [Related]
3. The F.D.A.'s callous response to AIDS.
Kramer L
N Y Times Web; 1987 Mar; ():A19. PubMed ID: 11646190
[No Abstract] [Full Text] [Related]
4. Implications of the federal drug investigation and approval processes for the development and availability of AIDS treatments and vaccines.
Mathers PR
AIDS Public Policy J; 1987; 2(2):50-3. PubMed ID: 11650030
[No Abstract] [Full Text] [Related]
5. U.S. permits AIDS patients to use unproved drug.
Kolata G
N Y Times Web; 1989 Jan; ():A1, B6. PubMed ID: 11646713
[No Abstract] [Full Text] [Related]
6. Twice wrong on AIDS.
Gieringer D
N Y Times Web; 1987 Jan; ():A21. PubMed ID: 11646161
[No Abstract] [Full Text] [Related]
7. AIDS treatment drugs: clinical trials and compassionate use.
Levine RJ
AIDS Public Policy J; 1987; 2(2):6-8. PubMed ID: 11650031
[No Abstract] [Full Text] [Related]
8. Trial of experimental AIDS drug to be continued, with revisions.
Kolata G
N Y Times Web; 1990 Mar; ():A1, A15. PubMed ID: 11646750
[No Abstract] [Full Text] [Related]
9. Experimental drugs: more of them, but they're no longer free.
Caplan J
Hastings Cent Rep; 1987 Jun; 17(3):3. PubMed ID: 11644019
[No Abstract] [Full Text] [Related]
10. Shaking up the status quo: how AIDS activists have challenged drug development and approval procedures.
Dunbar MM
Food Drug Cosmet Law J; 1991 Sep; 46(5):673-706. PubMed ID: 11651380
[No Abstract] [Full Text] [Related]
11. FDA treatment use regulations: a compassionate response.
Weitzman SA; Marcy T
AIDS Public Policy J; 1987; 2(2):22-32. PubMed ID: 11650028
[No Abstract] [Full Text] [Related]
12. A chance at life for AIDS sufferers.
Krim M
N Y Times Web; 1986 Aug; ():A27. PubMed ID: 11646177
[No Abstract] [Full Text] [Related]
13. The FDA's response to AIDS: paradigm shift in new drug policy?
Podraza R
Food Drug Law J; 1993; 48(3):351-75. PubMed ID: 11653267
[No Abstract] [Full Text] [Related]
14. Faith (healing), hope and charity at the FDA: the politics of AIDS drug trials.
Annas GJ
Villanova Law Rev; 1989 Sep; 34(5):771-97. PubMed ID: 11651162
[No Abstract] [Full Text] [Related]
15. The right of privacy in choosing medical treatment: should terminally ill persons have access to drugs not yet approved by the Food and Drug Administration?
Power SH
John Marshall Law Rev; 1987; 20(4):693-714. PubMed ID: 11650094
[No Abstract] [Full Text] [Related]
16. Private rights to adulterated/misbranded articles.
McMonagle L
AIDS Public Policy J; 1987; 2(2):33-49. PubMed ID: 11650029
[No Abstract] [Full Text] [Related]
17. AIDS study casts doubt on value of hastened drug approval in U.S.
Altman LK
N Y Times Web; 1993 Apr; ():C3. PubMed ID: 11646977
[No Abstract] [Full Text] [Related]
18. Making experimental drugs available for AIDS treatment.
Krim M
AIDS Public Policy J; 1987; 2(2):1-5. PubMed ID: 11650026
[No Abstract] [Full Text] [Related]
19. Getting new drugs to people with AIDS: a public policy response to Lansdale.
Cohen MN
Hastings Constit Law Q; 1991; 18(3):471-85. PubMed ID: 11651493
[No Abstract] [Full Text] [Related]
20. Should the rules be bent in an epidemic?
Eckholm E
N Y Times Web; 1986 Jul; ():E30. PubMed ID: 11646165
[No Abstract] [Full Text] [Related]
[Next] [New Search]